RSS Feed

• 4. Lucid May 13, 2024
  Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), today announced that three manuscripts providing interim results from the Prospective REView of Esophageal Precancer DetectioN in AT-Risk Patients (PREVENT) Registry, the CLinical Utility of EsoGuard (CLUE) study, and […]
• 2. LiveNova May 13, 2024
  LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation, has achieved a positive predictive outcome and will conclude enrollment earlier than anticipated. This means there is a greater than 97.5% probability that the OSPREY trial will successfully meet its primary […]
• 3. Join us and PlatformQ Health May 13, 2024
  Join us and PlatformQ Health to gain valuable insights on treating chronic lymphocytic #leukemia in this informative #CME session. Click here to tune in to review recent #ClinicalTrial data on second-generation BTKIs and their potential to provide safer treatment for #CLL.
• 0. In the evolving landscape of medical care May 13, 2024
  In the evolving landscape of medical care, collaboration between different specialties is proving to be a game-changer for patients dealing with complex conditions. One such collaborative effort that stands out is the partnership between interventional pain physicians and spine surgeons in managing lumbar spinal stenosis (LSS). This contemporary approach aims to provide patients with a […]
• 1. Boston Scientific Corporation May 13, 2024
  On March 1st, Boston Scientific Corporation announced U.S. Food and Drug Administration (FDA) approval for the AGENT™ Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. The AGENT DCB addresses a […]
• Study: ACO leaders share priorities, challenges in Medicare Shared Savings Program May 13, 2024
  A study reveals key insights from leaders of 49 accountable care organizations involved in the Medicare Shared Savings Program. They discuss various strategic approaches and obstacles, emphasizing the importance of annual wellness visits, accurate patient coding and effective care transitions to enhance patient care.
• 00. On April 18th, 2024 May 13, 2024
  On April 18th, 2024, the U.S. Food and Drug Administration (FDA) approved a subcutaneous (SC) administration of ENTYVIO® (vedolizumab) for maintenance therapy in adults with moderately to severely active Crohn's disease (CD). This follows the September 2023 FDA approval of ENTYVIO SC in adults with moderately to severely active ulcerative colitis (UC). The safety and […]
• Exploring the connections between mental health and our environment May 13, 2024
  This special report delves into the intricate connections between mental health and environmental factors. It highlights the biopsychosocial model's evolution, emphasizing the need for a broader perspective that includes environmental impacts on mental health.
• AI can tell if a patient battling cancer needs mental health support May 13, 2024
  Researchers at UBC and BC Cancer have developed an AI model that analyzes oncologists' notes to predict if cancer patients might require mental health services. This AI, using natural language processing, has over 70% accuracy in identifying patients likely to benefit from psychiatric support within a year, marking a significant advancement in integrating AI into […]
• Genes known to increase the risk of Alzheimer's may actually be an inherited form of the disorder, researchers say May 13, 2024
  A new study in "Nature Medicine" suggests a possibly distinct, inheritable form of Alzheimer's is linked to a specific gene, necessitating unique testing and treatment strategies. This research differentiates between familial Alzheimer's, which occurs early due to gene mutations and more common sporadic cases that develop later in life.